Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTOR | Stock Option (Right to Buy) | Award | $0 | +1.5M | $0.00 | 1.5M | Aug 12, 2024 | Common Stock | 1.5M | $2.15 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024. |
F2 | This Form 4 has been amended to correct the amount of option shares held by the Reporting Person. |